SOLN
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Washington H Soul Pattinson & Company Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Washington H Soul Pattinson & Company Limited - Ordinary Fully Paid Deferred Ex Milton Corp Ltd
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$40.40
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in SOLN
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in SOLN
N/A
SOLN investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in SOLN also invest in...
Want more shares? Try these...
SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-08-27. The firm provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. The company is focused on the commercialization of the SomnoDent and other oral devices for sleep-related disorders. Its SomnoDent product line includes SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite and Herbst Advance. Its SomMorning Repositioner is designed to help return their mandible back to its pre-treatment centric position. Its SomnoBrux Michigan splint is a custom fit, acrylic splint (dental guard) for upper teeth designed to protect the teeth from grinding and scraping during Bruxism. The company also offers SomTabs, which are cleaning tablets that are developed to clean oral appliances safely.
📊 Share price
$0.85 AUD
Washington H. Soul Pattinson & Co. Ltd. engages in the ownership of shares; coal mining; distribution and retail of pharmaceutical products; and manufacture of building products. The company is headquartered in Sydney, New South Wales. WHSP’s segments include Strategic portfolio, Large caps portfolio, Emerging companies portfolio, Private equity portfolio, Structured yield portfolio and Property portfolio. Strategic portfolio comprises investments in uncorrelated listed companies where WHSP has board representation. Large caps portfolio managed, Australian listed equities portfolio. The portfolio seeks to generate consistent income and capital growth over the long term. Emerging companies portfolio invests in attractive, early-stage and high growth companies that are listed, about to undertake an Initial Public Offering (IPO) or at a pre-IPO stage. Private equity portfolio Includes long term investments in unlisted companies to support their future growth. Structured yield portfolio contains investments in corporate loans and hybrid instruments. Property portfolio includes investments in property development joint ventures.
📊 Share price
$33.25 AUD
NULL GLOBAL
NULL SMART BETA
NULL ACTIVE